News
NAION is a rare form of vision loss that’s been linked to semaglutide, the active ingredient in Wegovy and Ozempic.
The I'm A Celebrity star, 76, has joined the growing number of celebrities and influencers turning to jabs such as ...
According to NPR, doctors and patients alike have noted the drug has appeared to reduce some people's cravings for booze, ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
The approval was based on Part 1 (72 week data) of the randomized, double-blind, placebo-controlled phase 3 ESSENCE trial.
The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for ...
Novo Nordisk’s stock popped Monday after it announced a cash discount for uninsured Ozempic users and gained FDA approval for ...
Researchers urged caution, recommending that diabetic patients on GLP-1 therapies undergo regular eye screening….
Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and comments from ...
Six in ten Brits (61 per cent) believe the correct modern etiquette is to call ahead of a dinner or lunch party - to notify ...
GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies across the U.S.
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results